Type 2 & other diabetes

MDRD is the estimated glomerular filtration rate (eGFR) equation most strongly associated with 4-year mortality among patients with diabetes in Colombia

BMJ Open Diabetes Res CarePublished Retrospective cohort study

Authors' conclusion

Compared with other eGFR equations, MDRD showed the strongest association with all-cause mortality in a sample of Latin-American patients with diabetes. This difference was most pronounced among patients of black race.

Study context

Population
Adults with diabetes assisted by the Colombian Health System, July 1, 2015–June 30, 2019; 58% female, 7.2% black race, mean age 62.3, HbA1c 7.4%
Participants
758,219 adults
Exposure
eGFR by Cockcroft-Gault vs MDRD vs CKD-EPI vs CKD-EPI without race (CKD-EPI-NR) and 4-year all-cause mortality
Outcome
All-cause mortality
Follow-up
4-year
Methodological detailsnationwide, centralized database
  • Nationwide
  • Centralized database

Main finding

As reported in the abstract

Discrimination of survival status (area under ROC curve) by eGFR equation
AUC greatest for MDRD, followed by CKD-EPI-NR, CKD-EPI and Cockcroft-Gault, in that order
p<0.001 for all differences
Odds of death decreased per additional mL/min of eGFR (each equation, continuous)
1.1%-1.5%

Observational data: associations, not effects.

Further findings

Black race: adjusted OR of mortality, chronic kidney disease (CKD) stage 4 vs stage 1

aOR (95% CI)
MDRDStage 4vs stage 14.63 (3.39–6.35)
CKD-EPI-NRStage 4vs stage 13.66 (2.85–4.69)
CKD-EPIStage 4vs stage 13.01 (2.38–3.81)
Cockcroft-GaultStage 4vs stage 12.82 (2.29–3.49)

Deaths over follow-up

Deaths
35,296

Original publication

MDRD is the eGFR equation most strongly associated with 4-year mortality among patients with diabetes in Colombia. BMJ Open Diabetes Res Care. Published 20 July 2023. doi:10.1136/bmjdrc-2023-003495

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.